A detailed history of Legacy Financial Strategies, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Legacy Financial Strategies, LLC holds 715 shares of LLY stock, worth $575,303. This represents 0.16% of its overall portfolio holdings.

Number of Shares
715
Previous 694 3.03%
Holding current value
$575,303
Previous $539,000 20.04%
% of portfolio
0.16%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$724.87 - $909.04 $15,222 - $19,089
21 Added 3.03%
715 $647,000
Q1 2024

Apr 10, 2024

BUY
$592.2 - $792.28 $36,124 - $48,329
61 Added 9.64%
694 $539,000
Q2 2023

Jul 28, 2023

SELL
$350.74 - $468.98 $14,380 - $19,228
-41 Reduced 6.08%
633 $296,000
Q4 2022

Feb 15, 2023

BUY
$321.55 - $374.67 $13,183 - $15,361
41 Added 6.48%
674 $246,000
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $176,436 - $207,161
633 New
633 $205,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $765B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Legacy Financial Strategies, LLC Portfolio

Follow Legacy Financial Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Financial Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Financial Strategies, LLC with notifications on news.